跳至主要内容
临床试验/CTRI/2022/06/043053
CTRI/2022/06/043053已完成2 期

A comparative clinical study to evaluate the efficacy of yapana basti and nasya along with shirobasti followed by kauncha paka in the management of kampavata with special reference to Parkinson’s disease (PD).

ational Institute of Ayurveda0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • . Patients between 40-70 years of age.
  • 2. Patients with clinical signs and symptoms of Kampavata/ PD.
  • 3. Patients of either sex irrespective of their occupation, religion and socio-economic
  • 4. Patients of Kampavata/PD who are fit for Shirobasti , Basti and Nasya.
  • 5. Patients willing to participate for interventional study.

排除标准

  • . Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem,
  • Uncontrolled Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc.
  • 2. Patients unfit for Shirobasti , Basti and Nasya.

研究者

相似试验